|
|
||||||||
From the Movement Disorder Unit (Drs. Portman, Leenders, and Maguire and L. Veenmavan der Duin and J. Swart), Department of Neurology, University Hospital, Groningen, the Netherlands; the Movement Disorder Unit (Drs. Giladi, Simon, and HassinBaer), Department of Neurology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Israel; PET Center (Dr. Pruim), University Hospital, Groningen, the Netherlands; Sieratzki Chair of Neurology (Dr. Korczyn), Tel-Aviv University Medical School, Ramat-Aviv, Israel.
Address correspondence and reprint requests to Prof. Dr. K.L. Leenders, Groningen University Hospital, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, the Netherlands; e-mail: k.l.leenders{at}neuro.azg.nl
Nigrostriatal dopaminergic function and cerebral energy metabolism were measured with PET in two brothers with early-onset parkinsonism caused by mutation of the parkin gene. Energy metabolism did not differ, but the nigrostriatal dopaminergic pattern was clearly different than that of sporadic PD. Thus parkinsonism in these two patients was shown to be pathophysiologically different than PD.
This article has been cited by other articles:
![]() |
E. Lohmann, S. Thobois, S. Lesage, E. Broussolle, S. T. du Montcel, M. -J. Ribeiro, P. Remy, A. Pelissolo, B. Dubois, L. Mallet, et al. A multidisciplinary study of patients with early-onset PD with and without parkin mutations Neurology, January 13, 2009; 72(2): 110 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Adams, H. van Netten, M. Schulzer, E. Mak, J. Mckenzie, A. Strongosky, V. Sossi, T. J. Ruth, C. S. Lee, M. Farrer, et al. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation Brain, December 1, 2005; 128(12): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varrone, M. T. Pellecchia, M. Amboni, V. Sansone, E. Salvatore, D. Ghezzi, B. Garavaglia, A. Brice, A. Brunetti, V. Bonavita, et al. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease Neurology, December 14, 2004; 63(11): 2097 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scherfler, N. L. Khan, N. Pavese, L. Eunson, E. Graham, A. J. Lees, N. P. Quinn, N. W. Wood, D. J. Brooks, and P. P. Piccini Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism Brain, June 1, 2004; 127(6): 1332 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. J. Dekker, V. Bonifati, and C. M. van Duijn Parkinson's disease: piecing together a genetic jigsaw Brain, August 1, 2003; 126(8): 1722 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Tsai, P. S. Fishman, N. V. Thakor, and G. A. Oyler Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function J. Biol. Chem., June 6, 2003; 278(24): 22044 - 22055. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Khan, E. Graham, P. Critchley, A. E. Schrag, N. W. Wood, A. J. Lees, K. P. Bhatia, and N. Quinn Parkin disease: a phenotypic study of a large case series Brain, June 1, 2003; 126(6): 1279 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thobois, M.-J. Ribeiro, E. Lohmann, A. Durr, P. Pollak, O. Rascol, S. Guillouet, E. Chapoy, N. Costes, Y. Agid, et al. Young-Onset Parkinson Disease With and Without Parkin Gene Mutations: A Fluorodopa F 18 Positron Emission Tomography Study Arch Neurol, May 1, 2003; 60(5): 713 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Khan, D. J. Brooks, N. Pavese, M. G. Sweeney, N. W. Wood, A. J. Lees, and P. Piccini Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study Brain, October 1, 2002; 125(10): 2248 - 2256. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |